| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2008;51:127.)
© 2008 American Heart Association, Inc.
Original Articles |
From the Division of Cardiovascular Diseases (S.L., E.H.Y., A.P., V.M., G.W.B., C.S.R., L.O.L., A.L.) and Division of Nephrology and Hypertension (L.O.L.), Mayo Clinic, Rochester, Minn.
Correspondence to Amir Lerman, MD, Division of Cardiovascular Diseases, Mayo Clinic, Mary Brigh 4-523, First Street SW, Rochester, MN 55905. E-mail Lerman.Amir{at}mayo.edu
In vitro and animal studies suggest that oxidative stress is associated with endothelial dysfunction. We tested whether local oxidative stress and nitric oxide (NO) bioavailability in the coronary circulation is associated with coronary endothelial dysfunction in humans. Blood samples were obtained simultaneously from the left main coronary artery and the coronary sinus for measurement of F2-isoprostanes, myeloperoxidase, nitrotyrosine, and superoxide dismutase in 20 patients without significant coronary disease. Afterward, coronary blood flow and the vascular response to intracoronary acetylcholine and NG-monomethyl-L-arginine (L-NMMA) were assessed. The gradient of isoprostanes between the arterial levels and coronary sinus correlated with the change in coronary artery diameter in response to acetylcholine (r=–0.79, P<0.0001). Isoprostanes net production across the left anterior descending artery territory correlated with a decrease in superoxide dismutase activity (r=0.66, P=0.002) and decrease in coronary artery diameter in response to L-NMMA (rs=0.48, P<0.05). Myeloperoxidase and nitrotyrosine gradients were similar in patients with endothelial dysfunction and controls. The effect of L-NMMA was similar in both groups. We conclude that coronary endothelial dysfunction in humans is characterized by local enhancement of oxidative stress without a decrease in basal NO release. This study supports the hypothesis that local oxidative stress has a role in reduction of NO bioavailability in humans with coronary endothelial dysfunction.
Key Words: endothelial function oxidative stress nitric oxide acetylcholine
This article has been cited by other articles:
![]() |
S Lavi, J-H Bae, C S Rihal, A Prasad, G W Barsness, R J Lennon, D R Holmes Jr, and A Lerman Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques Heart, September 15, 2009; 95(18): 1525 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Torrens, C. J. Kelsall, L. A. Hopkins, F. W. Anthony, N. P. Curzen, and M. A. Hanson Atorvastatin Restores Endothelial Function in Offspring of Protein-Restricted Rats in a Cholesterol-Independent Manner Hypertension, April 1, 2009; 53(4): 661 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Pendyala, J. Li, T. Shinke, S. Geva, X. Yin, J. P. Chen, S. B. King III, K. A. Robinson, N. A.F. Chronos, and D. Hou Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 253 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox and A. Pearlman Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Klevay Endothelial Dysfunction, Isoprostanes, and Copper Deficiency Hypertension, September 1, 2008; 52(3): e27 - e27. [Full Text] [PDF] |
||||
![]() |
S. Lavi and A. Lerman Response to Endothelial Dysfunction, Isoprostanes, and Copper Deficiency Hypertension, September 1, 2008; 52(3): e28 - e28. [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin Oxidative Stress, Nitric Oxide Synthase, and Superoxide Dismutase: A Matter of Imbalance Underlies Endothelial Dysfunction in the Human Coronary Circulation Hypertension, January 1, 2008; 51(1): 31 - 32. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |